{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:09:43Z","timestamp":1782756583571,"version":"3.54.5"},"reference-count":41,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Literature offers plenty of cases of immunocompromised patients, who develop chronic and severe SARS-CoV-2 infections. The aim of this study is to provide further insight into SARS-CoV-2 evolutionary dynamic taking into exam a subject suffering from follicular lymphoma, who developed a persistent infection for over 7 months. Eight nasopharyngeal swabs were obtained, and were analyses by qRT-PCR for diagnostic purposes. All of them were considered eligible (Ct &lt; 30) for NGS sequencing. Sequence analysis showed that all sequences matched the B.1.617.2 AY.122 lineage, but they differed by few mutations identifying three genetically similar subpopulations, which evolved during the course of infection, demonstrating that prolonged replication is paralleled with intra-host virus evolution. These evidences support the hypothesis that SARS-CoV-2 adaptive capacities are able to shape a heterogeneous viral population in the context of immunocompromised patients. Spill-over of viral variants with enhanced transmissibility or immune escape capacities from these subjects is plausible.<\/jats:p>","DOI":"10.3390\/v15020291","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T02:43:29Z","timestamp":1674182609000},"page":"291","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient"],"prefix":"10.3390","volume":"15","author":[{"given":"Martina","family":"Brandolini","sequence":"first","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"},{"name":"Department of Experimental, Diagnostic and Specialty Medicine (DIMES)\u2014Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Zannoli","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gatti","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Arfilli","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Cricca","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"},{"name":"Department of Experimental, Diagnostic and Specialty Medicine (DIMES)\u2014Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Dirani","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Denicol\u00f2","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Semprini","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-3009","authenticated-orcid":false,"given":"Laura","family":"Grumiro","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Imola","sequence":"additional","affiliation":[{"name":"Unit of Ematology, AUSL Romagna, 47900 Rimini, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Larne","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, AUSL Romagna, 47900 Rimini, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Michela","family":"Marino","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Manera","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mancini","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-2082","authenticated-orcid":false,"given":"Francesca","family":"Taddei","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-1477","authenticated-orcid":false,"given":"Manuel","family":"Zagarrigo","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC)\u2014Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Biagetti","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, AUSL Romagna, 47900 Rimini, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5012-7355","authenticated-orcid":false,"given":"Vittorio","family":"Sambri","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy"},{"name":"Department of Experimental, Diagnostic and Specialty Medicine (DIMES)\u2014Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_3","unstructured":"World Health Organization (2022, November 30). Coronavirus Disease (COVID-2019) Dashboard, Available online: https:\/\/covid19.who.int\/."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"24614","DOI":"10.1073\/pnas.2017726117","article-title":"Low genetic diversity may be an Achilles heel of SARS-CoV-2","volume":"117","author":"Rausch","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","unstructured":"World Health Organization (2022, November 30). Tracking SARS-CoV-2 Variants, Available online: https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41564-021-00932-w","article-title":"SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse","volume":"6","author":"Konings","year":"2021","journal-title":"Nat. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"12479","DOI":"10.1038\/s41598-022-16533-4","article-title":"Mutational induction in SARS-CoV-2 major lineages by experimental exposure to neutralising sera","volume":"12","author":"Brandolini","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.abf6950","article-title":"Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape","volume":"371","author":"McCarthy","year":"2021","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.cell.2021.03.027","article-title":"SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms","volume":"184","author":"Clark","year":"2021","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e0024421","DOI":"10.1128\/mSphere.00244-21","article-title":"Long-term evolution of SARS-CoV-2 in an immunocompromised patient with non-Hodgkin lymphoma","volume":"6","author":"Borges","year":"2020","journal-title":"mSphere"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chen, L., Zody, M.C., Mediavilla, J.R., Cunningham, M.H., Composto, K., Chow, K.F., Kordalewska, M., Corvelo, A., Oschwald, D.M., and Fennessey, S. (medRxiv, 2021). Emergence of multiple SARS-CoV-2 antibody escape variants in an immunocompromised host undergoing convalescent plasma treatment, medRxiv, preprint.","DOI":"10.1101\/2021.04.08.21254791"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/cid\/ciab392","article-title":"Bamlanivimab treatment leads to rapid selection of immune escape variant carrying E484K mutation in a B.1.1.7 infected and immunosuppressed patient","volume":"73","author":"Lohr","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"veac080","DOI":"10.1093\/ve\/veac080","article-title":"The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK","volume":"8","author":"Hill","year":"2022","journal-title":"Virus Evol."},{"key":"ref_15","unstructured":"Cepheid (2022). Xpert\u00ae Xpress SARS-CoV-2\u2014Instruction for Use, Cepheid."},{"key":"ref_16","unstructured":"Diasorin (2022). LIAISON\u00ae SARS-CoV-2 TrimericS IgG Assay\u2014Instruction for Use, Diasorin."},{"key":"ref_17","unstructured":"Abbott Laboratories (2021). AdviseDx SARS-CoV-2 Anti-NP IgG\u2014Instruction for Use, Abbott Laboratories."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1515\/CCLM.2007.199","article-title":"IFCC Taskforce on Etichs. IFCC Position Paper: Report of the IFCC Taskforce on Ethics: Introduction and framework","volume":"45","author":"Burnett","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_19","unstructured":"Paragon Genomics (2021). CleanPlex\u00ae SARS-CoV-2 FLEX Research and Surveillance Panels, Paragon Genomics."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"veab064","DOI":"10.1093\/ve\/veab064","article-title":"Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool","volume":"7","author":"Scher","year":"2021","journal-title":"Virus Evol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104351","DOI":"10.1016\/j.meegid.2020.104351","article-title":"Emergence of genomic diversity and recurrent mutations in SARS-CoV-2","volume":"83","author":"Acman","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/emph\/eoac010","article-title":"Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution","volume":"10","author":"Amicone","year":"2022","journal-title":"Evol. Med. Public Health"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","article-title":"Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer","volume":"183","author":"Avanzato","year":"2020","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41423-021-00654-3","article-title":"Systematic profiling of SARS-CoV-2 specific IgG epitopes at single amino acid resolution","volume":"18","author":"Qi","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1038\/s41467-021-25796-w","article-title":"Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential","volume":"12","author":"Meyer","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yamamoto, M., Tomita, K., Hirayama, Y., Inoue, J., Kawaguchi, Y., and Gohda, J. (medRxiv, 2022). SARS-CoV-2 Omicron spike H655Y mutation is responsible for enhancement of the endosomal entry pathway and reduction of cell surface entry pathways, medRxiv, preprint.","DOI":"10.1101\/2022.03.21.485084"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.2147\/IDR.S360103","article-title":"Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection","volume":"15","author":"Abebe","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1038\/s41467-021-26401-w","article-title":"Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Arora, P., Sidarovich, A., Graichen, L., H\u00f6rnich, B., Hahn, A., Hoffmann, M., and P\u00f6hlmann, S. (2022). Functional analysis of polymorphisms at the S1\/S2 site of SARS-CoV-2 spike protein. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0265453"},{"key":"ref_30","unstructured":"Rambaut, A., Loman, N., Pybus, O., Barclay, W., Barrett, J., Carabelli, A., Connor, T., Peacock, T., Robertson, D.L., and Volz, E. (2022, November 30). Preliminary Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in the UK Defined by a Novel Set of Spike mutations. Available online: https:\/\/virological.org\/t\/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations\/563."},{"key":"ref_31","unstructured":"Garry, R. (2022, November 30). Mutations Arising in SARS-CoV-2 Spike on Sustained Human-to-Human Transmission and Human-to-Animal Passage. Available online: https:\/\/virological.org\/t\/mutations-arising-in-sars-cov-2-spike-on-sustained-human-to-human-transmission-and-human-to-animal-passage\/578."},{"key":"ref_32","unstructured":"Stanford University (2023, January 16). Search SARS-CoV-2 Resistance Database\u2014Bamlanivimab (BAM) + Etesevimab (ETE). Available online: https:\/\/covdb.stanford.edu\/search-drdb\/?antibodies=Bamlanivimab%2CEtesevimab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10930-020-09901-4","article-title":"The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2 or n-COVD19), the Cause of COVID-19","volume":"39","author":"Yoshimoto","year":"2020","journal-title":"Protein J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"860891","DOI":"10.3389\/fimmu.2022.860891","article-title":"Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients with Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases","volume":"13","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(10)62175-7","article-title":"Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): A phase 3, randomised controlled trial","volume":"377","author":"Salles","year":"2011","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/2159-8290.CD-21-1033","article-title":"Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies","volume":"12","author":"Lee","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s42399-021-00790-x","article-title":"Reinfection or Reactivation of Coronavirus-19 in Patients with Hematologic Malignancies: Case Report Series","volume":"3","author":"Kapoor","year":"2021","journal-title":"SN Compr. Clin. Med."},{"key":"ref_38","unstructured":"Italian Institute of Public Health (2021). Stima Della Prevalenza Delle Varianti VOC (Variants of Concern) in Italia: Beta, Gamma, Delta, Omicron e Altre Varianti Di SARS-CoV-2. Report Del 06\/12\/2021, Italian Institute of Public Health."},{"key":"ref_39","unstructured":"Italian Institute of Public Health (2021). Stima Della Prevalenza Delle Varianti VOC (Variants of Concern) in Italia: Beta, Gamma, Delta, Omicron e Altre Varianti Di SARS-CoV-2. Report Del 20\/12\/2021, Italian Institute of Public Health."},{"key":"ref_40","unstructured":"Italian Institute of Public Health (2022). Stima Della Prevalenza Delle Varianti VOC (Variants of Concern) in Italia: Beta, Gamma, Delta, Omicron e Altre Varianti Di SARS-CoV-2. Report Del 03\/01\/2022, Italian Institute of Public Health."},{"key":"ref_41","unstructured":"Italian Institute of Public Health (2022). Stima Della Prevalenza Delle Varianti VOC (Variants of Concern) in Italia: Beta, Gamma, Delta, Omicron e Altre Varianti Di SARS-CoV-2. Report Del 31\/01\/2022, Italian Institute of Public Health."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/2\/291\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:11:07Z","timestamp":1760119867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/2\/291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["v15020291"],"URL":"https:\/\/doi.org\/10.3390\/v15020291","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,19]]}}}